by Baculovirus expression systems involve genetically engineering baculoviruses to produce recombinant proteins in insect cells. These systems are widely used for biomass production and therapeutic protein production due to their ability to perform post-translational modifications. They help in efficiently translating DNA sequences into functional proteins for various end-use industries like biopharmaceuticals and research.
The global Baculovirus Expression System Market is estimated to be valued at US$ 424.52 Bn in 2024 and is expected to exhibit a CAGR of 9.3% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Baculoviruses are capable of driving very high levels of expression of antigens suitable for vaccine development. They are widely used for developing vaccines against diseases like influenza, HIV/AIDS, hepatitis, and Ebola. Baculovirus expression systems minimize cell culture costs and provide high production yields, which is propelling their use in vaccine manufacturing. This is expected to significantly contribute to the market growth over the forecast period.
Segment Analysis
Baculovirus Expression System Market is dominated by recombinant proteins sub-segment. This sub-segment is dominating the market currently due to growing adoption of baculovirus expression system for production of large quantity of recombinant therapeutic proteins for disease treatment and viral vaccines for virus infections. Baculovirus expression system helps in mass production of recombinant proteins in shorter duration and with better yield as compared to traditional expression methods.
Key Takeaways
The Global Baculovirus Expression System Market Size is expected to witness high growth during the forecast period of 2024 to 2031 on account of increasing R&D investments in pharmaceutical and biotechnology companies for development of novel biologics. The global Baculovirus Expression System Market is estimated to be valued at US$ 424.52 Bn in 2024 and is expected to exhibit a CAGR of 9.3% over the forecast period 2024 to 2031.
Regional analysis related content comprises- North America region currently dominates the Baculovirus Expression System Market owing to presence of major players and growing biologics R&D activities. The Asia Pacific region is expected to witness fastest growth during the forecast period. This is attributed to factors such as increasing geriatric population, improving healthcare infrastructure and growing awareness about novel therapeutics.
Key players related content comprises- Key players operating in the Baculovirus Expression System Market are Motorola Solutions, JVCKENWOOD, Hytera Communications, Sepura, Simoco Wireless Solutions, Tait Communications, Codan Radio Communications, Cisco Systems, Harris Corporation, PowerTrunk. Major players are focusing on new product launches and geographical expansion strategies to strengthen their market position.
Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
